Courriel : bd@sidmexinovia.com
Téléphone : +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Sutykine 12.5mg Capsule
Manufacturer/Marketed By : INTAS PHARMACEUTICALS LTD
$4.92 $4.19
Sutykine 12.5mg Capsule consists of the active ingredient Sunitinib. It is classified as a tyrosine kinase inhibitor, which means it works by blocking certain enzymes called tyrosine kinases involved in...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
SUNITINIB
Active Pharmaceutical Ingredient
Sutykine 12.5mg Capsule
4,92 $US
4,19 $US
Sutykine 12.5mg Capsule consists of the active ingredient Sunitinib. It is classified as a tyrosine kinase inhibitor, which means it works by blocking certain enzymes called tyrosine kinases involved in the growth and spread of cancer cells. This medication treats gastrointestinal stromal tumors (GIST), rare cancer that can start anywhere in the gastrointestinal tract. This medication is also used to treat advanced kidney cancer and pancreatic cancer called pancreatic neuroendocrine tumors (PNET). Cancer is a disorder in which abnormal cells grow in an uncontrolled manner. It is not recommended for people under 18. Before taking Sutykine 12.5mg Capsule, it is important to discuss with the physician if you have blood conditions, heart problems, liver disorders, kidney problems, skin disorders, diabetes, seizures, or thyroid disorders. Also, inform if you have recently had or are about to have surgery. Tell your doctor if you are hypertensive because this medication sometimes causes hypertension as a side effect. Avoid taking grapefruit in any form during the treatment with Sutykine 12.5mg Capsule. Before starting treatment, check with your dentist if you have any problems in the mouth, such as mouth pain, swelling, or sores inside the mouth.
Active Pharmaceutical Ingredient
Uses
• Renal cell carcinoma (RCC)
• Gastrointestinal stromal tumors (GIST)
• Pancreatic neuroendocrine tumors (PNET)
• Medullary thyroid cancer
• Certain kidney cancer
Benefits
The therapeutic effects of Sutykine 12.5mg Capsule include slowing down or stopping the growth and spread of cancer cells in the body, thereby reducing the size and number of tumors. It works by inhibiting the activity of specific proteins known as tyrosine kinases, which are involved in the signaling pathways that control cell growth and division. It can help to prevent cancer cells from growing and spreading by blocking these pathways.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Side effects related to Sutykine 12.5mg Capsule are as follows:
Most Common Side Effects
• Fatigue
• Nausea and vomiting
• Diarrhoea
• Loss of appetite
• Hand-foot syndrome
• Skin discoloration or rash
• High blood pressure
• Headache
• Hair loss
• Changes in taste
• Dry skin or itching
• Nosebleeds
Common Side Effects
• Heart failure or heart attack
• Elevated liver function tests.
• Liver failure
• Proteinuria
• Acute kidney injury
• Interstitial lung disease (inflammation of lung walls)
• Pulmonary arterial hypertension
• Gastrointestinal perforation or fistula
• Haemorrhage (bleeding)
• Hypothyroidism (low thyroid function)
• Hypoglycemia (low blood sugar)
How To Use
Sutykine 12.5mg Capsule is taken orally, in the form of capsules, with a glass of water. The capsules should be swallowed whole and not crushed, chewed, or opened. The recommended dose may vary depending on the type of cancer being treated, the patient's age and weight, and other factors. This medication is usually taken once a day, with or without food, at around the same time each day. If you miss a dose, do not double the dose to compensate for the missed dose.
Safety Advice
• Breast Feeding: It is unknown whether Sutykine 12.5mg Capsule is excreted in human breast milk. Breastfeeding women should discuss the potential risks and benefits of the medication with their healthcare provider before starting treatment.
• Alcohol: It is generally recommended to avoid consuming alcohol during treatment with anticancer medication, as alcohol can potentially interfere with the effectiveness of the medication and increases liver-related and other potential side effects.
• Liver: Sutykine 12.5mg Capsules can cause liver toxicity, which can be severe or fatal in some cases. Patients taking this medication should be done their liver function tests regularly, and treatment should be interrupted or discontinued if these tests are abnormal.
• Lungs: Sutykine 12.5mg Capsule can cause interstitial lung disease (ILD), a serious and potentially fatal condition that causes scarring of the lungs. Patients taking this medication should be monitored for symptoms of ILD, such as cough, shortness of breath, and fever, and treatment should be interrupted or discontinued if necessary.
• Driving: Patients receiving Sutykine 12.5mg Capsule are advised to avoid driving or operating machinery if they experience side effects such as fatigue, dizziness, or blurred vision, impairing a patient's ability to drive or operate machinery safely.
• Pregnancy: Sutykine 12.5mg Capsule is unsafe for a developing fetus and is not recommended during pregnancy as it can cause harm to the developing fetus.
Disclaimer
Sidmex Inovia s'efforce de fournir des informations exactes et fiables. Cependant, l'ensemble du contenu de ce site web, y compris les descriptions et compositions des produits, est fourni à titre informatif uniquement et ne saurait se substituer à un avis, un diagnostic ou un traitement médical professionnel.
Il est conseillé aux utilisateurs de consulter un professionnel de santé qualifié avant toute décision médicale. Les informations fournies ne doivent pas être utilisées pour l'autodiagnostic ou l'automédication.
Tous les produits présentés sont exclusivement destinés aux professionnels (B2B) et aux demandes de renseignements en gros. Sidmex Inovia ne promeut pas la consommation directe par les particuliers et vise à soutenir, et non à remplacer, la relation entre le professionnel de santé et le patient.
Les noms de produits, marques et logos appartiennent à leurs propriétaires respectifs et leur utilisation n'implique aucune affiliation ni aucun parrainage. Sidmex Inovia décline toute responsabilité quant aux conséquences découlant de l'utilisation des informations fournies sur ce site web.